Skip to content
Riskpilot
← Tilbage til søgning
Log ind
Få fuld adgang
BIO-CONVERT A/S
A/S
Active
Reklamebeskyttelse
CVR 39842319
Vandtårnsvej 62A, 2860
Søborg
Manufacture of pharmaceutical preparations
·
NACE 2120
Est. 2018 · 7 years old
— employees
www.bio-convert.com
Overvåg
Share
Denmark
/
Companies
/
Manufacture of pharmaceutical preparations
/
BIO-CONVERT A/S
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Ledelse
Aktivt ansatte i selskabet
Name
Role
Member since
Current (1)
AT
Allan Traugott Wehnert
Management
Management
2024
Former (2)
TG
Tom Glæsner Larsen
Management
Management
2023 – 2024
NC
Nelli Carla Gotfredsen
Management
Management
2018 – 2022
Bestyrelse
Ikke-udøvende tilsyn
Name
Role
Member since
Current (3)
CT
Christian Torben Hill-Madsen
Board of Directors
Board of Directors
2025
PS
Peter Severin Bach
Chairman
Chairman
2024
HR
Henrik Rouf
Board of Directors
Board of Directors
2024
Former (2)
SS
Samia Sofie Kappe
Board of Directors
Board of Directors
2023 – 2024
HK
Henrik Keller
Board of Directors
Board of Directors
2024 – 2025
Aktionærer
Pr. seneste årsrapport
Shareholder
Type
Ownership
Votes
Since
Nordicus Partners Corporation
Individual
100%
100%
2024
ABCHill Holding ApS
Company
5–9.99%
5–9.99%
2024
Alteral Therapeutics ApS
Company
33.33–49.99%
33.33–49.99%
2023
GK PARTNERS ApS
Company
5–9.99%
5–9.99%
2024
Andreas Hill-Madsen
Individual
100%
100%
2018
AC Nordic ApS
Company
25–33.32%
25–33.32%
2024
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on BIO-CONVERT A/S
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network
